- Home
- » Tags
- » Oncolytic virus
Top View
- Oncolytic Adenovirus Programmed by Synthetic Gene Circuit for Cancer Immunotherapy
- Development of Group B Coxsackievirus As an Oncolytic Virus: Opportunities and Challenges
- Questing for an Optimal, Universal Viral Agent for Oncolytic Virotherapy
- Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity
- Cell-Derived Vesicles for Delivery of Cancer Immunotherapy Jialu Xu , Chao Wang *
- Emerging Technologies Updated
- Implications for Nigeria's Higher Education Curricular
- Conditionally Replicating Adenoviruses for Cancer Treatment
- Oncolytic Vaccinia Virus Reinvigorates Peritoneal Immunity and Cooperates with Immune Checkpoint Inhibitor to Suppress Peritoneal Carcinomatosis in Colon Cancer
- Discuss the Use of Oncolytic Viruses As Cancer Therapeutics
- A Repository of Oncolytic Viruses Used in Cancer Treatment
- Evolution of Oncolytic Viruses
- United States Patent (10) Patent No.: US 9,719,147 B1 Fernandez (45) Date of Patent: *Aug
- Transgene Codon Usage Drives Viral Fitness and Therapeutic Efficacy in Oncolytic Adenoviruses
- Genetically Stable Oncolytic RNA Virus, Method of Manufacturing and Use Thereof
- Oncolytic Virus Immunotherapy Meeting Review 2017
- Parking CAR T Cells in Tumours: Oncolytic Viruses As Valets Or Vandals?
- Developing Protein-Based Nanoparticles As Versatile Delivery Systems for Cancer Therapy and Imaging
- Oncolytic Viruses for Cancer Immunotherapy Otto Hemminki1,2,3* , João Manuel Dos Santos2,4 and Akseli Hemminki2,4,5*
- Vitualis' Medical Rants: Volume 2
- Oncolytic Viruses: the Next Major Breakthrough in Cancer Treatment
- Bovine Pestivirus Is a New Alternative Virus for Multiple Myeloma Oncolytic
- Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients with Multiple Myeloma
- Oncolytic Viral Therapies – the Clinical Experience
- View of the Proteins Encoded by the MV Genome and Their Functions Are Summarized Below
- Oncolytic Viruses and Their Application to Cancer Treatment Xie FZ and Zheng LL*
- Oncolytic Viruses: Focusing on the Tumor Microenvironment
- Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer
- Effect of Nacl on the Stability of Oncolytic Vaccinia Virus
- Arming Oncolytic Adenoviruses with Transgenes to Engage Stroma Toxicity and Immune Stimulation As a Double Strategy Against Cancer
- Clinical Application of Oncolytic Viruses: a Systematic Review
- Identification of in Vitro and in Vivo Oncolytic Effect in Colorectal Cancer
- Nanomedicine and Onco-Immunotherapy: from the Bench to Bedside to Biomarkers
- Qualifying Therapeutic Discovery Project Grants
- Enhancing the Antitumor Activity of Oncolytic Adenoviruses By
- Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
- Insights from a Minimal Model for Oncolytic Virotherapy
- Oncolytic Adenovirus Utilizing RNA Stabilization Mechanism Can Synergize with Chemotherapy
- Unleashing the Full Potential of Oncolytic Adenoviruses Against Cancer by Applying RNA Interference: the Force Awakens
- Lessons from Species Extinctions Viola Walther, Crispin T
- Phage Therapy in the Era of Synthetic Biology
- Intratumoral Coadministration of Hyaluronidase Enzyme And
- Improving Oncolytic Viral Therapy for Primary and Metastatic Tumors in the Brain
- The Emerging Role of Oncolytic Virus Therapy Against Cancer
- Oncolytic Virotherapy in Solid Tumors: the Challenges and Achievements
- Dynamical Behavior of a New Oncolytic Virotherapy Model Based on Gene Variation
- Perspectives on Immunotherapy Via Oncolytic Viruses Alberto Reale, Adriana Vitiello, Valeria Conciatori, Cristina Parolin, Arianna Calistri and Giorgio Palù*
- Phase 1 Study of Intravenous Administration of the Chimeric